Search results for: Mexico
Filter search results
Recently Published: Reports on Policy Options for Formulary Development in Middle-income Countries and A Case Study from Mexico
4 January 2017
…process. Download the full reports here: Policy Options for Formulary Development in Middle-income Countries Policy Options for Formulary Development in Middle-income Countries: Mexico Case Study A related publication is: Towse,…
Policy Options for Formulary Development in Middle-income Countries: Mexico Case Study
1 January 2017
PhRMA commissioned OHE Consulting to explore options and recommend methods that could help middle-income countries efficiently and effectively identify medicines for formulary inclusion. In a previous publication we presented a…
International Decision Support Initiative (iDSI): Mapping of priority-setting in health in 17 low and middle countries across Asia, Latin America, and Africa
1 April 2015
This mapping of priority-setting considers factors such as existence of HTA institutions and commitment to UHC (Brazil, Chile, Colombia, Mexico, Uruguay, Ghana, Kenya, Malawi, South Africa, Uganda, China, India, Indonesia,…
international Decision Support Initiative (iDSI): Mapping of Priority-setting in Health in 17 Low and Middle Income Countries Across Asia, Latin America and Africa
22 April 2015
This mapping of priority-setting considers factors such as existence of HTA institutions and commitment to UHC (Brazil, Chile, Colombia, Mexico, Uruguay, Ghana, Kenya, Malawi, South Africa, Uganda, China, India, Indonesia,…
OHE Achievements in 2018
27 December 2018
…the relevance of our work for NICE, DHSC and other health care organisations internationally. We are undertaking outcomes related work in Ireland, India, Mexico, Sweden, Canada, and China. OHE has…
Prices, Competition and Regulation in Pharmaceuticals: A Cross-National Comparison
1 June 2000
…H.R. Minority Staff, 1998) reported that drug prices in the US were 70 percent higher than in Canada and 102 percent higher than in Mexico. In the US, these studies…
Analysing Global Immunisation Expenditure
15 April 2025
…over the period of 2016 to 2022 across ten countries (Australia, Brazil, Canada, France, Germany, Italy, Japan, Mexico, South Korea and the United Kingdom). Key Findings Low spending on immunisation…
Policy Options for Formulary Development in Middle-income Countries
1 January 2017
PhRMA commissioned OHE Consulting to explore options and recommend methods that could help middle-income countries efficiently and effectively identify medicines for formulary inclusion. This report presents a framework for developing…